Skip to main content
Year archive

Checkpoint Trends Limited — 2019 filings

All 30 regulatory filings released by Checkpoint Trends Limited (531099) in 2019, sourced directly from the official regulator.

30 Filings
2019 Period
2019 filings (30)
Filing Released Lang
Cash Flow Statement For The Half Year Ended September 30, 2019
Regulatory Filings
2019-11-18 English
Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (LODR), 2015 For The half Year Ended September 30, 2019
Regulatory Filings
2019-11-15 English
Unaudited Financial Result For The Quarter Ended September 30, 2019 Alongwith Limited Review Report
Regulatory Filings
2019-11-14 English
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve Unaudited Standalone Financial ....
Regulatory Filings
2019-11-06 English
Compliance certificate for the half year ended September 30, 2019
Regulatory Filings
2019-10-25 English
Compliance Certificate For The Half Year Ended September 30, 2019
Regulatory Filings
2019-10-19 English
Outcome of AGM dated September 30, 2019
Regulatory Filings
2019-10-01 English
Notice of 28th Annual General Meeting of the Company
Regulatory Filings
2019-09-04 English
Annual Report of the Company for the FY 2018-19
Regulatory Filings
2019-09-03 English
Rubra Medicaments Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2019 to September 26, 2019 (both days inclusive) ....
Regulatory Filings
2019-08-10 English
Rubra Medicaments Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 09, 2019, inter alia, has considered and approved the following:- ....
Regulatory Filings
2019-08-09 English
Unaudited financial Result for the quarter ended June 30, 2019 alongwith Limited Review Report
Regulatory Filings
2019-08-09 English
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2019 ,inter alia, to consider and approve Unaudited Financial Result ....
Regulatory Filings
2019-07-30 English
Resignation of Company Secretary
Regulatory Filings
2019-07-04 English
Disclosure of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015 for the year ended March 31, 2019
Regulatory Filings
2019-06-22 English
Submission of ''Declaration on the Independent Auditors Report with unmodified opinion'' for the year ended March 31, 2019
Regulatory Filings
2019-06-18 English
Shifting of Registered office of the Company from the State of Telangana to the State of Maharashtra and consequential amendment to the domicile clause in the Memorandum of Association ....
Regulatory Filings
2019-06-13 English
Appointment of Mr. Gopal Sahu as Independent Director of the Company.
Regulatory Filings
2019-06-11 English
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/06/2019 ,inter alia, to consider and approve Appointment of Mr. Gopal ....
Regulatory Filings
2019-06-04 English
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period ....
Regulatory Filings
2019-05-24 English
Audited financial result for the year ended March 31, 2019
Regulatory Filings
2019-05-24 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2019-05-22 English
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2019 ,inter alia, to consider and approve Adoption of Standalone Audited ....
Regulatory Filings
2019-05-14 English
Cancellation of Warrants
Regulatory Filings
2019-04-25 English
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2019 ,inter alia, to consider and approve status of warrants allotted ....
Regulatory Filings
2019-04-18 English
Compliance Certificate For The Half Year Ended March 31, 2019
Regulatory Filings
2019-04-17 English
Certificate Under Regulation 40 (10) Of The SEBI (LODR) Regulations, 2015 For The Half Year Ended March 31, 2019
Regulatory Filings
2019-04-15 English
Adoption of Codes of Fair Disclosure and Conduct as per SEBI (Prohibition of Insider Trading) Regulations, 2015
Regulatory Filings
2019-03-28 English
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/03/2019 ,inter alia, to consider and approve Adoption of code of fair ....
Regulatory Filings
2019-03-19 English
Resignation of Independent Director
Regulatory Filings
2019-02-25 English